Abscess

Patient Population:
Pediatric
Condition Major Pathogens  First Choice Therapy Alternative Therapy Comments
Abscess of skin/soft tissue  

Staphylococcus aureus 

Other pathogens depending on specific exposures/risk factors 

Incision and drainage (I&D) is recommended for source control, though previous recommendations suggested I&D alone as an option for small abscesses without surrounding cellulitis, more recent studies have shown faster resolution when antibiotic therapy is given following I&D   

Outpatient/non-severe infection

Cephalexin  
25 mg/kg/dose (max 500 mg/dose) enterally tid  

------------------------- 

Inpatient/need for IV therapy

Cefazolin
25 mg/kg/dose (max 2000 mg/dose) IV q8h  

Severe infection (hemodynamic instability, end-organ dysfunction, or extensive local progression)

ID consult  

Penicillin or cephalosporin allergy with higher risk for allergic reaction 

OR 

History of documented MRSA infection or carriage within the last 6 months 

OR 

MRSA identified and susceptible to trimethoprim- sulfamethoxazole 

AND 

Age >=1 month:  

Trimethoprim-sulfamethoxazole (Bactrim)
5 mg trimethoprim/kg/dose (max 160 mg trimethoprim/dose) enterally bid 

Severe infection (hemodynamic instability, end-organ dysfunction, or extensive local progression)

ID consult 

With abscess I&D, send routine bacterial culture, follow-up result and modify therapy as indicated 

Duration: 5 days following source control for non-severe infection 

  

References: 

Stevens DL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014;59:e10-e52. 

Liu C, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-e55. 

Chen AE, et al. Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics. 2011 Mar;127(3):e573-80. 

Daum RS, et al. A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med 2017;376:2545-2555.

American Academy of Pediatrics. In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. Red Book: 2021 Report of the Committee on Infectious Diseases. 32nd ed. Elk Grove Village, IL: American Academy of Pediatrics; 2021.